Investors' Chronicle

Auteur(s): Investors' Chronicle
  • Résumé

  • Looking to stay informed in the world of investing? Investors' Chronicle dives into the key trends shaping today’s markets and unpacks what they mean for your investments. Featuring exclusive interviews with professional investors - whether fund managers or leading financial experts - our mission is to help you make smarter investment decisions.


    Investors' Chronicle is a service by the Financial Times.


    Hosted on Acast. See acast.com/privacy for more information.

    Investors' Chronicle
    Voir plus Voir moins
Épisodes
  • DeepSeek, Tesco & AJ Bell: The Companies and Markets Show
    Jan 31 2025

    Our panel kick off the podcast with a rundown of the latest news from the AI world. Chinese-owned DeepSeek’s smarter and more sustainable design helped knock half a billion dollars from Nvidia’s (NVIDIA) market cap. The panel discuss what comes next for AI stocks and return-hungry investors.


    It’s then on to Michael Fahy to chat about this week’s main feature on Tesco (TSCO). Michael explores how the supermarket's position has changed over the past few years, the mistakes it has made along the way and what comes next.


    Last up Val Cipriani and Julian Hoffman discuss AJ Bell’s (AJB) recent trading update. Listen to find out how the Budget has impacted the investing platform and how investors should consider the stock moving forward.


    Timestamps

    1:17 DeepSeek

    13:01 Tesco

    28:04 AJ Bell


    Claim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial

    *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you’re not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only.


    Hosted on Acast. See acast.com/privacy for more information.

    Voir plus Voir moins
    38 min
  • Predicting the market, US banks & biotech: The Companies and Markets Show
    Jan 24 2025

    On the week Donald Trump retook the position of US president, a handful of banking stocks released strong results. Jemma Slingo joins host Dan Jones to explore what investors need to know about Trump’s potential impact, the differences between UK and US banks, and a broader outlook for the year.


    It’s then onto this week’s cover feature on creating five-year outlooks for markets. Alex Newman runs through his thinking behind the piece, the challenges that arise when predicting market moves, and his predictions for gold.


    Last up, Julian Hoffman talks weight-loss drugs. He and Dan discuss what investors can expect in the year ahead, why Novo Nordisk’s results were disappointing, and more.


    Timestamps

    1:11 US banks

    12:22 A five-year outlook

    24:58 Biotech


    Claim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial

    *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you’re not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only.


    Hosted on Acast. See acast.com/privacy for more information.

    Voir plus Voir moins
    36 min
  • ‘Trusts need to do better’: Boaz Weinstein of Saba Capital
    Jan 21 2025

    Dave Baxter and Dan Jones sit down with the founder of Saba Capital, Boaz Weinstein. Last month, Saba sent the investment trust space into disarray by announcing it wanted to unseat board members at seven underperforming trusts, and merge them or offer shareholders a way out.


    In the episode, Dave and Dan grill Boaz on how Saba’s plans would work, what happens if it doesn’t win the votes, his belief that investors will benefit and more.


    The deadlines for shareholders to vote on Saba’s proposals vary, but in many cases, they are due before the end of January: check with your platform for details.


    How to vote in Saba's big investment trust battle


    Timestamps

    1:45 Are we too preoccupied with discounts?

    5:04 Critiques of Saba

    6:53 The plan when the results are in

    10:05 Professional investors’ view

    12:21 If they don’t win the votes

    15:01 Cash exits for trusts

    16:53 Trusts’ unlisted holdings eg. SpaceX

    19:57 The strategy for a new super-entity

    23:31 Where Saba’s attention will turn next

    25:55 If they win the vote, will they mimic US processes?

    28:10 Can Saba keep discounts in check?


    Claim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial

    *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you’re not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only.



    Hosted on Acast. See acast.com/privacy for more information.

    Voir plus Voir moins
    30 min

Ce que les auditeurs disent de Investors' Chronicle

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.